Patents by Inventor Alexander Graham Fallis

Alexander Graham Fallis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7935836
    Abstract: The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed permit the production of 2,9- and 2,10-disubstituted pentacene compounds and 2,6,9,13- and 2,6,10,13-tetrasubstituted compounds that present particularly advantageous properties for the manufacture of semiconductor materials, and may be used in devices such as for example thin film transistors and solar cells. These features are enhanced by ?-? parallel stacking in the solid state. Also disclosed are compounds that are excellent candidates for use in the manufacture of semiconductor materials, and other components of electronic systems, by virtue of their solubility, crystal packing geometries, and electronic properties.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: May 3, 2011
    Inventor: Alexander Graham Fallis
  • Patent number: 7655809
    Abstract: The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed permit the production of 2,9- and 2,10-disubstituted pentacene compounds that present particularly advantageous properties for the manufacture of semiconductor materials, and may be used in devices such as for example thin film transistors and solar cells. Also disclosed are compounds that are excellent candidates for use in the manufacture of semiconductor materials, and other components of electronic systems, by virtue of their solubility, crystal packing geometries, and electronic properties.
    Type: Grant
    Filed: May 17, 2005
    Date of Patent: February 2, 2010
    Assignee: University of Ottawa
    Inventors: Alexander Graham Fallis, Matthew Allen Heuft, Christophe Bénard
  • Publication number: 20100004467
    Abstract: The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed permit the production of 2,9- and 2,10-disubstituted pentacene compounds and 2,6,9,13- and 2,6,10,13-tetrasubstituted compounds that present particularly advantageous properties for the manufacture of semiconductor materials, and may be used in devices such as for example thin film transistors and solar cells. These features are enhanced by ?-? parallel stacking in the solid state. Also disclosed are compounds that are excellent candidates for use in the manufacture of semiconductor materials, and other components of electronic systems, by virtue of their solubility, crystal packing geometries, and electronic properties.
    Type: Application
    Filed: August 6, 2009
    Publication date: January 7, 2010
    Inventor: Alexander Graham FALLIS
  • Patent number: 7129250
    Abstract: This invention features ring-substituted pyrrolo-?-carboline derivatives and ring-substitution and structural derivatives of 3-(1H-indol-3-yl)-1H-pyrrole-2,5-dione of formulas I–III, which are useful as neuroprotective and anti-proliferative compounds. Also disclosed are methods for the preparation of these compounds, selected biological profiles and uses of these compounds in the treatment of various neurodegenerative and inflammatory diseases of the human nervous system and in the treatment of various other proliferative disorders characterized by loss of growth or cellular differentiation control including, but not limited to, cancer and inflammation.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: October 31, 2006
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Alexander Graham Fallis, John W. Gillard, Alain Laurent
  • Publication number: 20040220202
    Abstract: This invention features ring-substituted pyrrolo-&bgr;-carboline derivatives and ring-substitution and structural derivatives of 3-(1H-indol-3-yl)-1H-pyrrole-2,5-dione of formulas I-III, which are useful as neuroprotective and anti-proliferative compounds. Also disclosed are methods for the preparation of these compounds, selected biological profiles and uses of these compounds in the treatment of various neurodegenerative and inflammatory diseases of the human nervous system and in the treatment of various other proliferative disorders characterized by loss of growth or cellular differentiation control including, but not limited to, cancer and inflammation.
    Type: Application
    Filed: August 11, 2003
    Publication date: November 4, 2004
    Inventors: James B. Jaquith, Alexander Graham Fallis, John W. Gillard, Alain Laurent
  • Patent number: 4104286
    Abstract: A process is provided for isolating the crystalline chemical compound, cholesterol, from dried whole egg and dried egg yolk obtained from domestic hen eggs. This process provides not only free cholesterol, but also edible whole egg that is reduced in cholesterol and edible egg yolk powder that is reduced in cholesterol. The process includes extraction with aqueous ethanol, saponification in aqueous ethanolic alkali metal hydroxide, and concentration and purification with a hydrocarbon solvent and methanol. The products obtained include free cholesterol, essentially cholesterol-free edible egg powder, i.e., either whole egg or egg yolk, and saponified fats, recovered in the form of their salts.
    Type: Grant
    Filed: January 14, 1977
    Date of Patent: August 1, 1978
    Inventors: Alexander Graham Fallis, John Marshall William Scott, June Gertrude Winter